Trial intelligence / Profile preview

Muscadine Grape Extract in Men With Prostate Cancer on ADT

NCT03496805Phase 2Completed

Sponsor
Wake Forest University Health Sciences
Start
Jan 2019
Primary completion
Feb 2025
Modality
Dietary Supplement, PE (Plant Extract)
Countries
1
01

Overview

A Phase 2 trial of Muscadine Grape Skin Extract in prostate cancer (PCa), sponsored by Wake Forest University Health Sciences. Started Jan 2019; status: completed.

02

Drugs

Muscadine Grape Skin Extract
03

Conditions

prostate cancer (PCa)

Beyond the preview

Go deeper on NCT03496805.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03496805.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call